Attention: The information on this website is currently out of date and should not be relied upon..

Care Services

carehome, nursing and medical services directory


Synexus Merseyside Clinical Research Centre, South Wing, Liverpool.

Synexus Merseyside Clinical Research Centre in South Wing, Liverpool is a Diagnosis/screening specialising in the provision of services relating to diagnostic and screening procedures and services for everyone. The last inspection date here was 27th June 2013

Synexus Merseyside Clinical Research Centre is managed by Synexus Limited who are also responsible for 4 other locations

Contact Details:

    Address:
      Synexus Merseyside Clinical Research Centre
      Burlington House
      South Wing
      Liverpool
      L22 0LG
      United Kingdom
    Telephone:
      015192015555

Ratings:

For a guide to the ratings, click here.

Safe: No Rating / Under Appeal / Rating Suspended
Effective: No Rating / Under Appeal / Rating Suspended
Caring: No Rating / Under Appeal / Rating Suspended
Responsive: No Rating / Under Appeal / Rating Suspended
Well-Led: No Rating / Under Appeal / Rating Suspended
Overall: No Rating / Under Appeal / Rating Suspended

Further Details:

Important Dates:

    Last Inspection 2013-06-27
    Last Published 2013-06-27

Local Authority:

    Sefton

Link to this page:

    HTML   BBCode

Inspection Reports:

Click the title bar on any of the report introductions below to read the full entry. If there is a PDF icon, click it to download the full report.

23rd May 2013 - During a routine inspection pdf icon

On the day of our inspection, we were unable to speak with people who were attending appointments in relation to clinical trials. We asked the Quality Director for the contact details of three people, whom we could call at a later date to discuss their experiences of the service.

We telephoned one person who had been selected at initial stages to take part in a clinical trail. We asked how much information they had been given on the trial, what the trial involved, and about their experience from beginning to end. They explained to us, "The screening was very extensive; there were lots and lots of questions I had to answer." We asked how well informed they were about the drug involved in the trial. They told us, "I was given a lot of information about what type of drug was being tested and that it would be administered by self injection. I would have been taught to self administer if I had gone on to be suitable for the trial after the initial appointment with the doctor." We asked if this person had consented to their details being held for selection in future drug trials. They confirmed they had been asked for their consent in writing and had been given written information on how their personal details would be stored. They told us "Staff were very good at explaining what was involved at each stage in the process."

Throughout our inspection we found that people involved in clinical trials were well informed and that their well being was protected.

 

 

Latest Additions: